IQVIA™ Real-World Insights Bibliography

Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Author(s): Alejandra Martinez De Pinillos,?Isabel Ricote Lobera,?Cristina Martinez,?Caroline Anger,?Filippo Guglielmetti,?Roberto Jorge Bitton
Affiliations(s): IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publication(s):  Journal of Clinical Oncology?2019?37:15_suppl,?e20631-e20631
Document Type(s): Abstract,
Countries: France, Germany, Italy, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.
Author(s): Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2
Affiliations(s): 1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA
Publication(s):  Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Oncology,
2019
  L:
A:
English
Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
A REVIEW OF SWEDISH HEALTH TECHNOLOGY ASSESSMENTS BASED ON INDIRECT COMPARISONS OF HOSPITAL DRUGS IN ONCOLOGY
Author(s): Rongrong Zhang, Heller Vincent, Maximilian Schlueter, Ashley Pitcher
Affiliations(s): IQVIA
Publication(s):  ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Type(s): Abstract,
Countries: Sweden,
C:
Y:
Oncology,
2019
  L:
A:
English
Clinical setting: Home care, Review,
  Add to report
 
 
Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
Author(s): Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y
Affiliations(s): 
Publication(s):  Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019
Document Type(s): 
Countries: 
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Methodology,
  Add to report
 
 
Real-world evidence on patients with relapse/refractory FLT3 mutation-positive acute myeloid leukemia in Italy
Author(s): La Malfa P1, Arenga A1, De Santo E1, Urbinati D1
Affiliations(s): 1 IQVIA, Milan, Italy
Publication(s):  ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Oncology,
2019
  L:
A:
English
Real World Data, Real World Evidence,
  Add to report
 
 
Change in treatment paradigm of ALK+ Non-Small Cell Lung Cancer (NSCLC) in the Italian real practice
Author(s): Tucci C1, Urbinati D1, De Santo E1, Fico M2, Fioravanti L2, Demma F2
Affiliations(s): 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publication(s):  ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Oncology,
2019
  L:
A:
English
Public Health, Real World Data, Real World Evidence,
  Add to report
 
 
Brentuximab Vedotin for consolidation therapy after ASCT in CD30+ Hodgkin's limphoma: a sustainable pharmaceutical expenditure for the Italian National Health Service
Author(s): Peduto I1, Heiman F1, Morelli P2, Fioravanti L2, Demma F2
Affiliations(s): 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publication(s):  ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Oncology,
2019
  L:
A:
English
Cost analysis, Economic evaluation,
  Add to report
 
 
The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy
Author(s): Carnio S1, Galetta D2, Pilotto S3, Scotti V4, Cortionovis DL5, Antonuzzo A6, Pisconti S7, Rossi A8, Martelli O9, Cecere FL10, Lunghi A11, Del Conte A12, Montrone M2, Topulli J4, Canova S5, Rapetti SG1, Gianetta M1, Pacchiana MV1, Capelletto E1, Pegoraro V13, Cataldo N13, Bria E3 and Novello S1
Affiliations(s): 1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy 2 Clinical Cancer Center ?Giovanni Paolo II?, Bari, Italy 3 U.O.C. Oncology, Department of Medicine, University of Verona, Italy 4 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 5 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 6 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 7 Department of Onco-Ematology Medical Oncology, SG Moscati Hospital, Taranto, Italy 8 Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 9 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 10 Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy 11 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 12 IRCCS - Oncological Reference Center (CRO) - U.O. Oncology, Pordenone-S. Vito, Italy 13 IQVIA, Milan, Italy
Publication(s):  J Cancer Sci Ther 2018, 10:9
Document Type(s): Article,
Countries: Italy,
C:
Y:
Oncology,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden.
Author(s): Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T
Affiliations(s): Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde)
Publication(s):  Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15.
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis,
  Add to report
 
 
An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer.
Author(s): Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J.
Affiliations(s): 
Publication(s):  JCO Clinical Care Informatics 2019. 3:1-15.
Document Type(s): Article,
Countries: USA,
C:
Y:
Oncology,
2019
  L:
A:
English
  Add to report
 
 
 1 of 57 Next Page Last Page